Patent details

Basic Information

Publication number:

EP2009000

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP080154495

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

French Title of Invention:

Agonistes inverses de récepteur 2A/2C à sérotonine sélective en tant que thérapies pour les maladies neuro-dégénératives

German Title of Invention:

Selektive Serotonin-2A/2C-Rezeptor-Inversagonisten als Therapeutika für neurogenerative Erkrankungen

SPC Number:

Dates

Filing date:

15/01/2004

Grant date:

08/06/2011

EP Publication Date:

08/06/2011

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

31/12/2008

EP B1 Publication Date:

08/06/2011

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

15/01/2012

Expiration date:

15/01/2024

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/01/2004

 

 

Name:

Acadia Pharmaceuticals Inc.

Address:

3911 Sorrento Valley Blvd., San Diego, CA 92121-1402, United States (US)

Inventor

1

Name:

Uldam Allan K.

Address:

Denmark (DK)

2

Name:

Brann Mark R.

Address:

United States (US)

3

Name:

Weiner M.David

Address:

United States (US)

4

Name:

Davis Robert E.

Address:

United States (US)

5

Name:

Nash Norman

Address:

United States (US)

6

Name:

Andersson Carl-Magnus A.

Address:

Sweden (SE)

Priority

1

Priority Number:

441406 P

Priority Date:

16/01/2003

Priority Country:

United States (US)

2

Priority Number:

479346 P

Priority Date:

17/06/2003

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 211/06;

Filing date	Document type	Number of pages